Article
NRG1 Fusions in Breast Cancer
2020-09-18
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold> <italic>NRG1 </italic>gene fusions may be clinically actionable, since cancers carrying the fusion transcripts can be sensitive to tyrosine kinase inhibitors. The <italic>NRG1</italic> gene encodes ligands for the HER2(ERBB2)-ERBB3 heterodimeric receptor tyrosine kinase, and the gene fusions are thought to lead to autocrine stimulation of the receptor. The <itali...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 08828518-91c1-5e0d-a4e7-3c4296f3e67a
- DOI
- 10.21203/rs.3.rs-75553/v1
